Akebia Therapeutics
AKBA
#9606
Rank
ยฃ81.82 M
Marketcap
ยฃ0.29
Share price
-8.71%
Change (1 day)
-75.75%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2026 (TTM): -ยฃ0.12

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.12. In 2025 the company made an earnings per share (EPS) of -ยฃ0.01529 an increase over its 2024 EPS that were of -ยฃ0.25.

EPS history for Akebia Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.12685.67%
2025-ยฃ0.01529-93.94%
2024-ยฃ0.25-16.83%
2023-ยฃ0.30-23.7%
2022-ยฃ0.40-69.41%
2021-ยฃ1.30-38.63%
2020-ยฃ2.1217.37%
2019-ยฃ1.802.79%
2018-ยฃ1.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.11-4,274.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ4.01-3,381.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
ยฃ13.29-10,962.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-ยฃ5.12 4,087.50%๐Ÿ‡บ๐Ÿ‡ธ USA